Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
307 articoli
Targeting immune diseases before symptoms appear can delay clinical onset by over two years, offering new prevention strategies.
New research reveals how three types of helper T cells work together to trigger harmful autoimmune responses in tissues.
Two-year study shows aggressive treatment of axial spondyloarthritis reduces arterial plaque buildup by 73% when low disease activity is achieved.
Genetic variants of Epstein-Barr virus influence how well MS patients respond to interferon therapy, enabling personalized treatment.
Researchers mapped how rogue antibodies target MDA5, a critical immune protein, revealing new therapeutic targets for dermatomyositis.
New research shows lung ultrasound can detect life-threatening pulmonary complications in scleroderma patients with 100% sensitivity.
New research on targeted synthetic DMARDs during pregnancy shows increased preterm birth risk but limited overall data.
International study reveals concerning inconsistencies in myositis antibody testing that could affect diagnosis and treatment decisions.
Researchers analyzed 38 immune system structures to develop AI-powered, personalized treatments for autoimmune diseases.
Scientists discover how antibody feedback mechanisms control the development of long-lasting immune protection in specialized immune centers.
New research reveals how specialized immune cells in the gut could influence Parkinson's disease development and progression.
New research reveals how bacteria living inside cancer cells create immunosuppressive environments that help tumors metastasize.
